Removal of Pharmaceutical Micropollutants with Integrated Biochar and Marine Microalgae

利用生物炭和海洋微藻相结合的方法去除药物微污染物

阅读:2

Abstract

Using microalgae to remove pharmaceuticals and personal care products (PPCPs) micropollutants (MPs) have attracted considerable interest. However, high concentrations of persistent PPCPs can reduce the performance of microalgae in remediating PPCPs. Three persistent PPCPs, namely, carbamazepine (CBZ), sulfamethazine (SMT) and tramadol (TRA), were treated with a combination of Chaetoceros muelleri and biochar in a photobioreactor during this study. Two reactors were run. The first reactor comprised Chaetoceros muelleri, as the control, and the second reactor comprised Chaetoceros muelleri and biochar. The second reactor showed a better performance in removing PPCPs. Through the response surface methodology, 68.9% (0.330 mg L(-1)) of CBZ, 64.8% (0.311 mg L(-1)) of SMT and 69.3% (0.332 mg L(-1)) of TRA were removed at the initial concentrations of MPs (0.48 mg L(-1)) and contact time of 8.1 days. An artificial neural network was used in optimising elimination efficiency for each MP. The rational mean squared errors and high R(2) values showed that the removal of PPCPs was optimised. Moreover, the effects of PPCPs concentration (0-100 mg L(-1)) on Chaetoceros muelleri were studied. Low PPCP concentrations (<40 mg L(-1)) increased the amounts of chlorophyll and proteins in the microalgae. However, cell viability, chlorophyll and protein contents dramatically decreased with increasing PPCPs concentrations (>40 mg L(-1)).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。